Sunday, 22 November 2026Independent journalism • Sierra Leone & Beyond
NEWS FLASHLatest Sierra Leone and international news

India develops first locally made H5N1 bird flu vaccine to protect chickens

India develops first locally made H5N1 bird flu vaccine to protect chickens

India has developed its first locally made vaccine against the H5N1 bird flu virus, marking a new step in efforts to protect poultry farms from a disease that has caused major losses in the country’s agricultural sector.

The vaccine was developed by scientists at the Indian Council of Agricultural Research’s National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal after years of research and trials.

According to a report published by The New Indian Express on 19 November 2026, the vaccine is designed to protect chickens against a highly dangerous strain of avian influenza that has affected poultry farms in India. The New Indian Express

The vaccine uses an inactivated formulation targeting the H5N1 Clade 2.3.2.1a strain, which has been circulating in the country.

Highly Pathogenic Avian Influenza (HPAI), commonly known as bird flu, is a viral disease that can spread rapidly among poultry and cause severe illness and death in infected birds.

Outbreaks often force authorities to destroy large numbers of chickens and other poultry to prevent the disease from spreading.

These measures can result in financial losses for farmers, reduce poultry production and affect the supply of chicken meat and eggs.

The development of the vaccine is expected to provide another tool for controlling the disease and reducing the impact of future outbreaks.

India has experienced repeated outbreaks of bird flu over the past two decades.

Between 2006 and 2021, the country recorded 341 outbreaks across 24 states, according to figures cited in the report.

Of these, 284 were linked to the H5N1 virus, while 57 involved the H5N8 strain.

Scientists say the newly developed vaccine specifically targets a strain of H5N1 for which India previously lacked a dedicated vaccine.

Aniket Sanyal, Director of ICAR-NIHSAD, described the development as an important achievement for the country’s veterinary research sector.

He said the vaccine could help strengthen poultry health protection, support farmers and reduce India’s dependence on imported veterinary technology.

The H5N1 virus has also raised public health concerns because some strains can infect mammals and humans, although the new vaccine has been developed for poultry rather than people.

The vaccine is not intended for human use and does not replace existing measures to monitor and control bird flu outbreaks.

For poultry farmers, vaccination could provide additional protection against a disease that can destroy entire flocks and disrupt business operations.

India’s poultry industry supports farmers, traders and other businesses involved in food production and distribution.

A major outbreak can affect these activities through the loss of birds, restrictions on poultry movement and reduced consumer confidence.

The report noted that India’s 2006 bird flu outbreak caused estimated direct and indirect economic losses of between 2,200 crore and 3,000 crore rupees.

The development of the locally made vaccine comes as Indian authorities continue efforts to strengthen disease prevention and improve the country’s ability to respond to animal health emergencies.

India’s Union Agriculture Minister, Shivraj Singh Chouhan, officially unveiled the vaccine on Friday, 20 November 2026, in Bhopal. Officials confirmed that it was the country’s first domestically developed vaccine targeting the H5N1 Clade 2.3.2.1a strain. The New Indian Express

The unveiling marks a move from research and development towards wider use, although the reports did not provide a confirmed timetable for nationwide distribution or details about how farmers would obtain the vaccine.

The vaccine’s wider impact will depend on its availability, how vaccination programmes are implemented and continued monitoring of bird flu outbreaks.

Source: Salone Messenger
AUTHOR
Sallu Kamuskay
Sallu Kamuskay

Sallu Kamuskay is a Sierra Leonean journalist, digital media producer and development-focused storyteller committed to amplifying voices from underreported communities and connecting local realities to global conversations.

Related Stories